PATH | VRL
Menu

Investigating Live Attenuated Influenza Vaccine Efficacy in Senegal

This fact sheet describes a Phase 3 clinical study that PATH and its partners are conducting in Senegal to evaluate the clinical efficacy of a seasonal, trivalent live attenuated influenza vaccine (LAIV). By providing evidence on how well this type of vaccine works among young children in Senegal, this study will help inform efforts in the scientific community to develop optimal LAIVs for the world’s most vulnerable children, as well as policy decisions for potential future LAIV use in Senegal and other tropical, low-resource countries in Africa.

Author: PATH

Published: 2013

» Download file (English)

120 KB PDF

» Download file (French)

120 KB PDF

Also known as: Analyse de l'Efficacité du Vaccin Antigrippal Vivant Atténué au Sénégal

Resource types: PATH resource, Fact sheet

Diseases/vaccines: Influenza

Topics: Vaccine safety and performance, Disease/vaccine specific information

Regions: Africa